The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Sp316
CONTEXT IS KEY: WHEN TO CONSIDER PROBIOTICS OR MICROBIOME TESTING FOR NEONATES, INFANTS, AND CHILDREN
BACKGROUND: Physiologic cholestasis is prevalent in preterm infants, occurring in ~15% of preterm births. Cholestasis causes poor neonatal growth and may progress to liver failure and death. Underlying causes of most cases are unknown…
SOCIETY: AGA This session will focus on the current debates about utility of small intestinal microbiome, probiotics and microbiome testing. The first debate will focus on "The Microbiome Conundrum: Unraveling the Influence of Small Intestinal Microbes on GI Symptoms - Debating Our Path Ahead"…
SOCIETY: AGA This session is focused on the early life microbiome and its importance for immune maturation that affects both childhood diseases as well as future development of allergic and autoimmune diseases…
SOCIETY: AGA In this session, presenters will provide insights into pioneering nutrition interventions and microbiome modulation strategies from studies that span both pediatric and adult patients…